Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 14, 2023; 29(2): 223-231
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.223
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.223
Table 1 Irreversible electroporation of pancreatic cancer in animal models
Ref. | Animal model | n | Tumour location | Histology | Major complication |
Charpentier et al[27], 2010 | Porcine | 4 | NP | Necrosis | None |
Bower et al[28], 2011 | Porcine | 6 | Orthotopic PC | Necrosis | None |
Joséet al[29], 2012 | Mouse | 24 | Orthotopic PC | Necrosis | None |
Fritz et al[33], 2015 | Porcine | 10 | Orthotopic PC | Necrosis | None |
Su et al[30], 2018 | Mouse | 22 | Orthotopic PC | Necrosis | None |
Shankara Narayanan et al[31], 2018 | Mouse | N/A | Subcutaneous/orthotopic PC | Necrosis | None |
Lee et al[32], 2021 | Porcine | N/A | Orthotopic PC | Necrosis | None |
- Citation: Spiliopoulos S, Reppas L, Filippiadis D, Delvecchio A, Conticchio M, Memeo R, Inchingolo R. Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. World J Gastroenterol 2023; 29(2): 223-231
- URL: https://www.wjgnet.com/1007-9327/full/v29/i2/223.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i2.223